GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » cbdMD Inc (AMEX:YCBD) » Definitions » Gross Profit

cbdMD (YCBD) Gross Profit : $11.84 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is cbdMD Gross Profit?

cbdMD's gross profit for the three months ended in Dec. 2024 was $3.40 Mil. cbdMD's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $11.84 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. cbdMD's gross profit for the three months ended in Dec. 2024 was $3.40 Mil. cbdMD's Revenue for the three months ended in Dec. 2024 was $5.11 Mil. Therefore, cbdMD's Gross Margin % for the quarter that ended in Dec. 2024 was 66.52%.

cbdMD had a gross margin of 66.52% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 10 years, the highest Gross Margin % of cbdMD was 77.34%. The lowest was 20.32%. And the median was 62.96%.


cbdMD Gross Profit Historical Data

The historical data trend for cbdMD's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

cbdMD Gross Profit Chart

cbdMD Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.37 29.99 22.34 14.98 12.00

cbdMD Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.56 2.58 3.40 2.45 3.40

Competitive Comparison of cbdMD's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Gross Profit distribution charts can be found below:

* The bar in red indicates where cbdMD's Gross Profit falls into.


;
;

cbdMD Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

cbdMD's Gross Profit for the fiscal year that ended in Sep. 2024 is calculated as

Gross Profit (A: Sep. 2024 )=Revenue - Cost of Goods Sold
=19.482 - 7.486
=12.00

cbdMD's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=5.113 - 1.712
=3.40

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.84 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

cbdMD's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=3.40 / 5.113
=66.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


cbdMD  (AMEX:YCBD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

cbdMD had a gross margin of 66.52% for the quarter that ended in Dec. 2024 => Durable competitive advantage


cbdMD Gross Profit Related Terms

Thank you for viewing the detailed overview of cbdMD's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


cbdMD Business Description

Traded in Other Exchanges
Address
2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Executives
Thomas Ronan Kennedy officer: Interim CEO and CFO 8845 RED OAK BLVD, CHARLOTTE NC 28217
Bakari T. Sellers director 4231 VOORHEES ROAD, DENMARK SC 29042
Raines William F Iii director 8314 TOSOMOCK LANE, HUNTERSVILLE NC 28078
Scott G. Stephen director 4249 NORTH WINCHESTER AVE., CHICAGO IL 60613
Sibyl Nichole Swift director 730 HAWTHORNE LANE, APT 441, CHARLOTTE NC 28204
Kevin Macdermott officer: President 9580 CALDWELL RD, MOUNT ULLA NC 28125
Wiesehan John J Iii officer: Chief Revenue Officer 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Sim Farar director 8845 RED OAK BOULEVARD, CHARLOTTE NC 28217
Martin A. Sumichrast director, officer: Chairman of the Board and CEO 11125 COLONIAL COUNTRY LANE, CHARLOTTE NC 28277
Raymond Scott Coffman director 230 S. TRYON ST., #1302, CHARLOTTE NC 28202
Peter J. Ghiloni director 115 DEER ESTATES LANE, PONTE VEDRA BEACH FL 32082
Mark S Elliott officer: CFO & COO C/O LEVEL BRANDS, INC., 4521 SHARON ROAD, SUITE 450, CHARLOTTE NC 28211
Gregory C Morris director 421 CRANBORNE CHASE, FORT MILL SC 29708
Caryn Nicole Dunayer officer: President 8476 CATAWBA DOVE DR., BELMONT NC 28012
Erik Sterling 10 percent owner 5505 KALANIANAOLE HWY, HONOLULU HI 96821

cbdMD Headlines

From GuruFocus

Q2 2021 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2020 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2025 cbdMD Inc Earnings Call Transcript

By GuruFocus News 02-14-2025

Q1 2022 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q3 2024 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 08-16-2024

Q4 2020 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q1 2021 cbdMD Inc Earnings Call Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

cbdMD Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

Q4 2024 cbdMD Inc Earnings Call Transcript

By GuruFocus News 12-27-2024